Gene · 5818
NECTIN1: nectin cell adhesion molecule 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NECTIN1: nectin cell adhesion molecule 1. Genes, record 5818. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5818
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q15223 | Nectin-1 | 517 | 6 | Ensembl, GeneID, HGNC |
Source UniProt
Patents51
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4777615 A1 | 2026-07-22 | 24 | Q15223 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 58293 | Q15223 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2286 | Q15223 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1856 | Q15223 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 113 | Q15223 | Espacenet |
| EP 4641203 A2 | 2025-10-29 | 72 | Q15223 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 9286 | Q15223 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 2817 | Q15223 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7128 | Q15223 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 2817 | Q15223 | Espacenet |
1 to 10 of 51
See all 51 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,464
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NECTIN1 papers | Newest fiscal year |
|---|---|---|---|
| P30EY001792 | P30 Core Grant for Vision Research | 27 | 2025 |
| P01CA163205 | Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas | 14 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 13 | 2025 |
| R01EY024710 | A new molecular therapy against ocular herpes | 12 | 2025 |
| P30DK034989 | Yale Liver Center | 9 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 8 | 2025 |
| R01DK099097 | Functional outcomes of inflammatory bowel disease associated variants | 8 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 7 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 6 | 2025 |
| P30DK034854 | Integrated Epithelial and Muscosal Biology | 6 | 2025 |
1 to 10 of 2,464Source NIH's project files
See all 2,464 nih grantsPapers3,675
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Age-stratified adverse-event reporting signals of seven ALK/ROS1 tyrosine kinase inhibitors in FAERS: a disproportionality and time to onset study. | Front Pharmacol | 2026 | 42769117 | PubTator, text mining | PubMed |
| Sphingosine 1-phosphate signalling contributes to transforming growth factor-β1-induced myofibroblast differentiation in oral cancer. | PeerJ | 2026 | 42730290 | PubTator, text mining | PubMed |
| Microbial adhesion promotes Piezo1 activation to initiate innate immunity. | Nat Immunol | 2026 | 42717253 | PubTator, text mining | PubMed |
| The TRIM-cancer paradox: BCG as a programmable vaccine platform and a mechanistic probe for rational immunotherapy design. | Front Immunol | 2026 | 42683335 | PubTator, text mining | PubMed |
| Rare missense variants in NECTIN1 alter local protein structure and may contribute to non-syndromic cleft lip with or without palate. | Front Genet | 2026 | 42657432 | PubTator, text mining | PubMed |
| Early-onset respiratory adverse event patterns of omalizumab in pediatric patients: an age-stratified FAERS pharmacovigilance study. | Acta Clin Belg | 2026 | 42647060 | PubTator, text mining | PubMed |
| Safety Comparison of Acetylcholinesterase Inhibitors Using FAERS Spontaneous-Reporting Data: Drug-Specific Reporting Signals and Time-to-Onset Dynamics. | Curr Alzheimer Res | 2026 | 42634550 | PubTator, text mining | PubMed |
| Conjugated NOD1-Centered Dual Agonists Exhibit Modest In Vitro Immunomodulation but Potent In Vivo Adjuvanticity. | ACS Bio Med Chem Au | 2026 | 42630639 | PubTator, text mining | PubMed |
| Emergence and molecular characterization of bovine alphaherpesvirus 1 subtype 1.1 in China, with in vivo characterization in a rabbit model. | Microb Pathog | 2026 | 42628886 | PubTator, text mining | PubMed |
| Intestinal Flora and Myocarditis: Potential Mechanisms and Therapeutic Strategies Affecting Disease Progression and Cardiac Function. | Int J Mol Sci | 2026 | 42589363 | PubTator, text mining | PubMed |
1 to 10 of 3,675
See all 3,675 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5818
GET https://conductscience.org/api/genes/v1/5818/patents?page=2